Sun Pharmaceuticals v. Eli Lilly: Doctrine of Obviousness-Type Double Patenting
A remarkable latest change in the Patentability has risen from the decision of the Federal Circuit in the case Sun Pharmaceuticals v. Eli Lilly, over the later’s patent that claimed the use of gemcitabine (GEMZAR), a drug to treat cancer.…